Literature DB >> 15601818

Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.

Gordon W McLean1, Noboru H Komiyama, Bryan Serrels, Hidefumi Asano, Louise Reynolds, Francesco Conti, Kairbaan Hodivala-Dilke, Daniel Metzger, Pierre Chambon, Seth G N Grant, Margaret C Frame.   

Abstract

We have generated mice with a floxed fak allele under the control of keratin-14-driven Cre fused to a modified estrogen receptor (CreER(T2)). 4-Hydroxy-tamoxifen treatment induced fak deletion in the epidermis, and suppressed chemically induced skin tumor formation. Loss of fak induced once benign tumors had formed inhibited malignant progression. Although fak deletion was associated with reduced migration of keratinocytes in vitro, we found no effect on wound re-epithelialization in vivo. However, increased keratinocyte cell death was observed after fak deletion in vitro and in vivo. Our work provides the first experimental proof implicating FAK in tumorigenesis, and this is associated with enhanced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15601818      PMCID: PMC535910          DOI: 10.1101/gad.316304

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  21 in total

1.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 2.  The role of growth factors in mouse skin tumor promotion and premalignant progression.

Authors:  S H Yuspa; H Hennings; A Dlugosz; T Tennenbaum; A Glick
Journal:  Prog Clin Biol Res       Date:  1995

3.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.

Authors:  M Quintanilla; K Brown; M Ramsden; A Balmain
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

4.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.

Authors:  K Shibata; F Kikkawa; A Nawa; A A Thant; K Naruse; S Mizutani; M Hamaguchi
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

5.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

Authors:  C J Kemp; L A Donehower; A Bradley; A Balmain
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

6.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors.

Authors:  L V Owens; L Xu; R J Craven; G A Dent; T M Weiner; L Kornberg; E T Liu; W G Cance
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

7.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

8.  Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice.

Authors:  T S Argyris
Journal:  J Invest Dermatol       Date:  1980-10       Impact factor: 8.551

Review 9.  Focal adhesion kinase: at the crossroads of signal transduction.

Authors:  D Ilić; C H Damsky; T Yamamoto
Journal:  J Cell Sci       Date:  1997-02       Impact factor: 5.285

10.  Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation.

Authors:  A Stoler; R Kopan; M Duvic; E Fuchs
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

View more
  110 in total

1.  Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling.

Authors:  Emma Sandilands; Bryan Serrels; David G McEwan; Jennifer P Morton; Juan Pablo Macagno; Kenneth McLeod; Craig Stevens; Valerie G Brunton; Wallace Y Langdon; Marcos Vidal; Owen J Sansom; Ivan Dikic; Simon Wilkinson; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2011-12-04       Impact factor: 28.824

2.  Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells.

Authors:  Emma Sandilands; Bryan Serrels; Simon Wilkinson; Margaret C Frame
Journal:  EMBO Rep       Date:  2012-06-26       Impact factor: 8.807

3.  Dieckol from Ecklonia cava suppresses the migration and invasion of HT1080 cells by inhibiting the focal adhesion kinase pathway downstream of Rac1-ROS signaling.

Authors:  Sun Joo Park; You Jin Jeon
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

4.  Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells.

Authors:  Robert F Klees; Roman M Salasznyk; Scott Vandenberg; Kristin Bennett; George E Plopper
Journal:  Matrix Biol       Date:  2006-10-13       Impact factor: 11.583

Review 5.  FIP200, a key signaling node to coordinately regulate various cellular processes.

Authors:  Boyi Gan; Jun-Lin Guan
Journal:  Cell Signal       Date:  2007-11-01       Impact factor: 4.315

Review 6.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

7.  Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.

Authors:  Huaping Fan; Xiaofeng Zhao; Shaogang Sun; Ming Luo; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.

Authors:  Ken Kataoka; Dae Joon Kim; Steve Carbajal; John L Clifford; John DiGiovanni
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

9.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

Authors:  Ming Luo; Huaping Fan; Tamas Nagy; Huijun Wei; Chenran Wang; Suling Liu; Max S Wicha; Jun-Lin Guan
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

Authors:  Yuliya Pylayeva; Kelly M Gillen; William Gerald; Hilary E Beggs; Louis F Reichardt; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.